Management of malignancy in HIV infection.
The prevalence of HIV-related malignant disease is increasing, probably due to more effective management of opportunistic infection. The most frequent tumours are Kaposi's sarcoma, systemic non-Hodgkin's lymphoma and primary central nervous system lymphoma. Management of these conditions must take into account host indicators of immunosuppression and prognostic outcome in order to minimise treatment associated complications.
Denton
A S
AS
Meyerstein Institute of Radiotherapy and Oncology, Middlesex Hospital, London, UK.
Spittle
M F
MF
D015658:HIV Infections / Q000150:complications*; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000473:pathology / Q000628:therapy; D008228:Lymphoma, Non-Hodgkin / Q000209:etiology / Q000473:pathology / Q000628:therapy; D009369:Neoplasms / Q000209:etiology* / Q000473:pathology / Q000628:therapy; D012514:Sarcoma, Kaposi / Q000209:etiology / Q000473:pathology / Q000628:therapy